Pioneering Targeted Covalent Therapies
Transforming the treatment of drug resistance
Transforming the treatment of drug resistance
At Ankaa Therapeutics, our mission is to develop innovative covalent therapies to address drug resistance. By leveraging cutting edge research and technology we are at the forefront of addressing unmet medical needs and transforming the treatment landscape
University of Massachusetts Medical School
S6-213 M2D2 Incubator Labs
55 Lake Avenue North
Worcester
MA 01655
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.